BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Bought by Wolverine Asset Management LLC

Wolverine Asset Management LLC raised its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 260.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 274,318 shares of the company’s stock after purchasing an additional 198,177 shares during the period. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $4,019,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Carmel Capital Partners LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter valued at approximately $92,000. Stratos Wealth Advisors LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at approximately $170,000. CWM LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 1,212,300.0% in the 4th quarter. CWM LLC now owns 12,124 shares of the company’s stock valued at $178,000 after acquiring an additional 12,123 shares during the last quarter. Blue Bell Private Wealth Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 229.3% in the 3rd quarter. Blue Bell Private Wealth Management LLC now owns 14,792 shares of the company’s stock valued at $213,000 after acquiring an additional 10,300 shares during the last quarter. Finally, Ieq Capital LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter valued at approximately $223,000.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE BMEZ traded down 0.10 during trading on Wednesday, reaching 14.67. The stock had a trading volume of 245,704 shares, compared to its average volume of 328,637. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.59. The firm’s 50 day moving average price is 15.91 and its two-hundred day moving average price is 14.94.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be paid a dividend of $0.09 per share. The ex-dividend date of this dividend is Friday, April 12th. This represents a $1.08 dividend on an annualized basis and a yield of 7.36%.

Insider Buying and Selling

In related news, major shareholder Saba Capital Management, L.P. acquired 264,206 shares of the stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average cost of 15.41 per share, for a total transaction of 4,071,414.46. Following the purchase, the insider now directly owns 18,313,103 shares in the company, valued at 282,204,917.23. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders purchased a total of 1,942,490 shares of company stock worth $30,632,636 in the last three months.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.